Volume 21, Number 7—July 2015
Research
Malaria Prevalence among Young Infants in Different Transmission Settings, Africa
Table 3
Anti–MSP119 antibody seropositivity and Plasmodium falciparum parasite prevalence among children in different transmission settings, Africa*
Country, age group | Parasite prevalence, no. (%)† | Antibody seropositive, no. (%) | p value |
---|---|---|---|
The Gambia, N = 2,270 | |||
0–6 mo | 25 (3.4) | 33 (5.7) | 0.044 |
1–9 y | 8 (1.0) | 53 (7.0) | <0.001 |
10–15 y |
21 (2.7) |
57 (8.1) |
<0.001 |
Benin, N = 2,276 | |||
0–6 mo | 25 (3.3) | 269 (36.5) | <0.001 |
1–9 y | 201 (26.5) | 303 (41.5) | <0.001 |
10–15 y |
284 (37.6) |
311 (42.5) |
0.054 |
Guinea, N = 2,215 | |||
0–6 mo | 133 (18.4) | 299 (41.6) | <0.001 |
1–9 y | 574 (76.7) | 339 (45.9) | <0.001 |
10–15 y | 612 (82.4) | 320 (44.2) | <0.001 |
*MSP119, 19-kDa merozoite surface protein.
†Prevalence as determined by microscopy.
Page created: June 12, 2015
Page updated: June 12, 2015
Page reviewed: June 12, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.